Om Sri Surgi-Med Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.50 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.84 Cr
- Satisfied Charges ₹ 8.00 M
- Revenue Growth -1.82%
- Profit Growth 2.56%
- Ebitda 10.22%
- Net Worth 10.99%
- Total Assets 10.88%
About Om Sri Surgi-Med
Om Sri Surgi-Med Private Limited (OSSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 May 2010 and has a history of 14 years and nine months. Its registered office is in Darjiling, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹1.84 Cr. The company has closed loans amounting to ₹8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Debarun Bhattacharjee, Priyatosh Dey, Dhilan Biswas, and One other member serve as directors at the Company.
Company Details
-
Location
Darjiling, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232WB2010PTC146481
-
Company No.
146481
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 May 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Om Sri Surgi-Med?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debarun Bhattacharjee
|
Director | 03-May-2010 | Current |
|
Priyatosh Dey
|
Director | 03-May-2010 | Current |
|
Dhilan Biswas
|
Director | 03-May-2010 | Current |
|
Debabrata Roy
|
Director | 03-May-2010 | Current |
Financial Performance of Om Sri Surgi-Med.
Om Sri Surgi-Med Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.82% decrease. The company also saw a slight improvement in profitability, with a 2.56% increase in profit. The company's net worth Soared by an impressive increase of 10.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Om Sri Surgi-Med?
In 2023, Om Sri Surgi-Med had a promoter holding of 87.94% and a public holding of 12.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹18.40 M
₹8.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Sep 2014 | State Bank Of India | ₹1.84 Cr | Open |
| 06 Aug 2010 | Bank Of India | ₹8.00 M | Satisfied |
How Many Employees Work at Om Sri Surgi-Med?
Unlock and access historical data on people associated with Om Sri Surgi-Med, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Om Sri Surgi-Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Om Sri Surgi-Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
